| ID | Name | CAS |
MW (g/mol) |
| 82-250-3 |
Succinic acid, 2,2,3,3,4,4,5,5-octafluoropentyl (2-chlorocyclohexyl)methyl ester
|
| 462.76 |
| 79-344-3 |
Thorium,chlorotris(«eta»5-2,4-cyclopentadien-1-yl)-
|
1284-82-8 | 462.77 |
| 96-600-9 |
allo-Cholanic acid, 7«beta»-hydroxy, Me-TMS
|
| 462.78 |
| 98-240-7 |
allo-Cholanic acid, 7«alpha»-hydroxy, Me-TMS
|
| 462.78 |
| 98-241-6 |
Cholanic acid, 12«alpha»-hydroxy, Me-TMS
|
| 462.78 |
| 98-239-9 |
Cholanic acid, 7«alpha»-hydroxy, Me-TMS
|
| 462.78 |
| 62-701-4 |
allo-Cholanic acid, 3«beta»-hydroxy, Me-TMS
|
| 462.78 |
| 13-184-3 |
3-«beta»-Hydroxy-5-«beta»-cholanoic acid, MeTMS
|
| 462.78 |
| 98-243-4 |
Cholanic acid, 12«beta»-hydroxy, Me-TMS
|
| 462.78 |
| 16-182-2 |
Cholan-24-oic acid, 3-[(trimethylsilyl)oxy]-, methyl ester, (3«alpha»,5«beta»)-
|
59953-47-8 | 462.78 |
| 98-237-1 |
allo-Cholanic acid, 12«beta»-hydroxy, Me-TMS
|
| 462.78 |
| 70-094-0 |
allo-Cholanic acid, 3«alpha»-hydroxy, Me-TMS
|
| 462.78 |
| 98-242-5 |
Cholanic acid, 7«beta»-hydroxy, Me-TMS
|
| 462.78 |
| 47-768-8 |
Isolithocholic acid, trimethylsilyl ether-methyl ester
|
| 462.78 |
| 39-549-0 |
Cholanic acid, 3«alpha»-hydroxy, Me-TMS
|
| 462.78 |
| 88-424-4 |
(Z)-Hentriacont-22-ene-2,4-dione
|
305805-41-8 | 462.79 |
| 32-518-1 |
4,5-Dipropyl-4,5-bis-(4-tert-butylphenyl)octane
|
85668-72-0 | 462.79 |
| 31-335-5 |
6«beta»-Hydroxy-17«alpha»-Methyltestosterone, bis-TMS
|
| 462.81 |
| 114-973-5 |
Silane, dimethyl(2,6-dimethylnon-1-en-3-yn-5-yloxy)silyloxy)(2,6-dimethylnon-1-en-3-yn-5-yloxy)-
|
| 462.81 |
| 29-730-9 |
7«beta»-Hydroxy kaurenoic acid, TMS
|
| 462.81 |
| 37-575-3 |
2-Oxacholesterol, TMS
|
| 462.82 |
| 121-490-3 |
Silane, diethylheptadecyloxy(2-phenylethoxy)-
|
| 462.82 |
| 113-509-1 |
Silane, diethylhexadecyloxy(1-phenylpropoxy)-
|
| 462.82 |
| 114-258-9 |
Silane, diethyl(3,5-dimethylphenoxy)heptadecyloxy-
|
| 462.82 |
| 117-255-9 |
Silane, diethylhexadecyloxy(4-isopropylphenoxy)-
|
| 462.82 |
| 119-962-2 |
Silane, diethylhexadecyloxy(3-phenylpropoxy)-
|
| 462.82 |
| 34-059-9 |
3-Hydroxydodecanedioic acid, tris(O-trimethylsilyl)
|
81089-39-6 | 462.84 |
| 76-588-6 |
Silane, [[(3«alpha»)-pregn-5-ene-3,20-diyl]bis(oxy)]bis[trimethyl-
|
55515-25-8 | 462.86 |
| 19-389-0 |
Pregnenediol, TMS
|
| 462.86 |
| 25-512-5 |
17-«beta»-Hydroxy-7-«alpha»,17-«alpha»-dimethyl-5-«beta»-androstan-3-one, per-TMS
|
| 462.86 |
| 50-901-5 |
Bis(trimethylsilyl)derivative of 3«beta»,20«beta»-dihydroxypregn-5-ene
|
33283-11-3 | 462.86 |
| 26-268-6 |
20«beta»-Dihydropregnenolone, MO-TMS
|
| 462.86 |
| 67-791-0 |
5-Pregnen-3-«beta»,11-«beta»-diol, TMS
|
| 462.86 |
| 33-960-9 |
Silane, [[(3«beta»,20S)-pregn-5-ene-3,20-diyl]bis(oxy)]bis[trimethyl-
|
13110-77-5 | 462.86 |
| 29-544-6 |
4-Pregnen-3-«beta»,20-«alpha»-diol, TMS
|
| 462.86 |
| 91-414-1 |
Bilobol C15:1 (2TMS)
|
| 462.86 |
| 33-408-2 |
5-Pregnen-3-«beta»,20-«alpha»-diol, MeTMS
|
| 462.86 |
| 21-076-4 |
4-Pregnen-3-«beta»,20-«beta»-diol, TMS
|
| 462.86 |
| 50-415-5 |
17-«alpha»-Hydroxy-7-«alpha»,17-«alpha»-dimethyl-5-«beta»-androstan-3-one, per-TMS
|
| 462.86 |
| 17-288-4 |
20«alpha»-Dihydropregnenolone, MO-TMS
|
| 462.86 |
| 45-575-4 |
4-Pregnen-3-«beta»,11-«beta»-diol, TMS
|
| 462.86 |
| 45-349-5 |
5-Pregnene-3«beta»,20«alpha»-diol, TMS
|
| 462.86 |
| 56-843-4 |
isoascorbic acid, TMS
|
| 462.88 |
| 119-831-7 |
Shikimic acid (4TMS)
|
| 462.88 |
| 113-166-2 |
1-Cyclohexene-1-carboxylic acid, 3,4,5-tris[(trimethylsilyl)oxy]-, trimethylsilyl ester, [3R-(3«alpha»,4«alpha»,5«beta»)]-
|
55520-78-0 | 462.88 |
| 73-645-5 |
Tritriacont-9-ene
|
| 462.88 |
| 46-010-9 |
11-Triacontene
|
| 462.88 |
| 19-731-9 |
15-Tritriacontene
|
| 462.88 |
| 49-727-1 |
16-Tritriacontene
|
| 462.88 |
| 64-468-2 |
13-Tritriacontene
|
| 462.88 |
| 58-808-1 |
1-Tritriacontene
|
61868-11-9 | 462.88 |
| 13-916-0 |
Acridan, 2-chloro-9-(3-dimethylaminopropyl)-10-ethyl-, phosphate (1 to 1),dihydrate
|
| 462.90 |
| 72-136-1 |
cis-Cyclohex-4-en-1,2-dicarboxylic acid, 4-chloro-3-methylphenyl dodecyl ester
|
| 463.05 |
| 83-038-8 |
Cholesteryl chloroacetate
|
3464-50-4 | 463.13 |
| 31-653-2 |
l-Serine, N,O-bis(3-trifluoromethylbenzoyl)-, methyl ester
|
| 463.33 |
| 41-843-0 |
l-Serine, N,O-bis(2-trifluoromethylbenzoyl)-, methyl ester
|
| 463.33 |
| 65-034-2 |
Uranium pentaethylate
|
10405-34-2 | 463.33 |
| 124-681-8 |
Sebacic acid, 4-bromo-2,6-difluorobenzyl isobutyl ester
|
| 463.35 |
| 27-083-0 |
Glutaric acid, 2,6-difluoro-4-bromobenzyl nonyl ester
|
| 463.35 |
| 124-920-2 |
Sebacic acid, 4-bromo-2,6-difluorobenzyl butyl ester
|
| 463.35 |
| 114-404-6 |
Succinic acid, 4-bromo-2,6-difluorobenzyl decyl ester
|
| 463.35 |
| 97-275-0 |
Phthalic acid, 5-bromo-2-methoxybenzyl heptyl ester
|
| 463.36 |
| 99-100-1 |
Phthalic acid, 2-(4-bromophenoxy)ethyl heptyl ester
|
| 463.36 |
| 119-082-9 |
Benzamide, 2,4,5-trifluoro-3-methoxy-N-(2,4,5-trifluoro-3-methoxybenzoyl)-N-3-methylbutyl-
|
| 463.37 |
| 119-083-8 |
Benzamide, 2,4,5-trifluoro-3-methoxy-N-(2,4,5-trifluoro-3-methoxybenzoyl)-N-pentyl-
|
| 463.37 |
| 60-382-1 |
N-Trifluoroacetyl-2,5-dimethoxy-4-trifluoroacetoxypropylthio-«beta»-phenethylamine
|
| 463.39 |
| 20-658-9 |
2,7-Naphthalenedisulfonic acid, 4-hydroxy-5(salicylideneamino)-, monosodium salt, hydrate
|
| 463.41 |
| 96-110-3 |
Coumarin, 6,7-bis(2-diethylaminoethoxy)-4-methyl-, dihydrochloride
|
| 463.44 |
| 119-250-2 |
L-Proline, N-(pentafluorobenzoyl)-, undecyl ester
|
| 463.48 |
| 121-179-9 |
Isonipecotic acid, N-pentafluorobenzoyl-, decyl ester
|
| 463.48 |
| 72-517-8 |
Phenylethanolamine, N-methyl, N-DTFMB-TMS
|
| 463.49 |
| 82-819-2 |
Succinic acid, 2,2,3,3,4,4,5,5-octafluoropentyl 2,2,2-trichloroethyl ester
|
| 463.53 |
| 50-362-4 |
1,3,5,7,2,4,6,8-Tetrazatetraphosphocine, 2,2,4,4,6,6,8,8-octachloro-2,2,4,4,6,6,8,8-octahydro-
|
2950-45-0 | 463.55 |
| 52-656-6 |
l-Methionine, n-pentafluoropropionyl-, dodecyl ester
|
| 463.55 |
| 73-968-7 |
Succinic acid, 2,4,6-trichlorophenyl pentafluorophenyl ester
|
| 463.57 |
| 77-338-2 |
Benzamide, pentafluoro-N-octadecyl-
|
| 463.57 |
| 35-062-4 |
Valsartan 2Me
|
| 463.57 |
| 61-926-6 |
Glutaric acid, 3-nitrophenethyl tridecyl ester
|
| 463.61 |
| 25-306-4 |
Glutaric acid, 4-methyl-3-nitrobenzyl tridecyl ester
|
| 463.61 |
| 53-024-6 |
Sebacic acid, decyl 2-nitrophenyl ester
|
| 463.61 |
| 43-684-5 |
2,4,5-TB PFB ester
|
| 463.61 |
| 91-402-4 |
Silane, diphenyl(3-nitrophenoxy)nonyloxy-
|
| 463.64 |
| 91-401-5 |
Silane, diphenyl(4-nitrophenoxy)nonyloxy-
|
| 463.64 |
| 49-100-6 |
2,6-Pyridinedicarboxylic acid, 3-(2-methoxyethyl)nonyl octyl ester
|
| 463.65 |
| 94-795-6 |
DL-Alanine, N-methyl-N-(2-benzyloxyethoxycarbonyl)-, tridecyl ester
|
| 463.65 |
| 15-305-6 |
2,6-Pyridinedicarboxylic acid, 5-methoxy-3-methylpent-2-yl tridecyl ester
|
| 463.65 |
| 47-189-1 |
2,6-Pyridinedicarboxylic acid, 1-methoxydec-4-yl nonyl ester
|
| 463.65 |
| 94-796-5 |
L-Leucine, N-methyl-N-(2-(benzyloxy)ethoxycarbonyl)-, decyl ester
|
| 463.65 |
| 114-169-8 |
L-Valine, N-(4-fluorobenzoyl)-, hexadecyl ester
|
| 463.67 |
| 123-958-2 |
L-Valine, N-(3-fluorobenzoyl)-, hexadecyl ester
|
| 463.67 |
| 98-184-0 |
Glycine, 2-cyclohexyl-N-(but-3-yn-1-yl)oxycarbonyl-, pentadecyl ester
|
| 463.69 |
| 96-579-4 |
L-Valine, N-(2-furoyl)-, octadecyl ester
|
| 463.69 |
| 59-527-2 |
1,3-Isobenzofurandione, 4,5,6,7-tetrabromo-
|
632-79-1 | 463.70 |
| 118-695-0 |
L-Proline, N-(cyclohexanecarbonyl)-, heptadecyl ester
|
| 463.74 |
| 60-859-2 |
Isonipecotic acid, N-(cyclohexylcarbonyl)-, hexadecyl ester
|
| 463.74 |
| 118-766-1 |
L-Proline, N-(3-cyclopentylpropionyl)-, hexadecyl ester
|
| 463.74 |
| 72-668-1 |
Glutaric acid, 8-chlorooctyl 4-bromo-2-methoxyphenyl ester
|
| 463.79 |
| 63-554-7 |
Hcys, N-isoBOC TBDMS
|
| 463.82 |
| 72-197-4 |
1,2-Cyclohexanedicarboxylic acid, octyl 2,4,6-trichlorophenyl ester
|
| 463.82 |
| 32-789-1 |
L-Cysteine, N,S-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
110024-94-7 | 463.94 |
|
« Previous Results
Next Results »
|